Deficiency of SCAMP5 Triggers Pancreatic β-Cell Secretory Dysfunction and Apoptosis

Area of Science:

• Endocrinology
• Molecular Biology
• Cell Biology

Background:

• Late-stage type 2 diabetes involves beta-cell dysfunction and apoptosis.
• Mechanisms driving beta-cell failure remain incompletely understood.
• The role of secretory carrier membrane protein 5 (SCAMP5) in beta-cells is unclear.

Purpose of the Study:

• To investigate the function of SCAMP5 in pancreatic beta-cells.
• To determine the role of SCAMP5 in diabetic beta-cell failure.
• To elucidate the molecular mechanisms underlying SCAMP5's function in beta-cells.

Main Methods:

• Assessed SCAMP5 expression in diabetic conditions.
• Investigated the impact of SCAMP5 deficiency on insulin secretion and apoptosis.
• Examined SCAMP5's interaction with voltage-dependent anion channel 1 (VDAC1).
• Analyzed the epigenetic regulation of SCAMP5 by carbohydrate-responsive element-binding protein (ChREBP).

Main Results:

• SCAMP5 expression is reduced in diabetic beta-cells.
• SCAMP5 deficiency impairs insulin secretion via reduced Ca_V1.2 expression.
• SCAMP5 prevents beta-cell apoptosis by inhibiting VDAC1-mediated cytochrome c release.
• Hyperglycemia-induced ChREBP epigenetically represses SCAMP5 expression.

Conclusions:

• SCAMP5 plays a vital role in maintaining beta-cell function and survival.
• The ChREBP-SCAMP5 axis is a key pathway in diabetic beta-cell failure.
• Targeting SCAMP5 may offer a novel therapeutic strategy for type 2 diabetes.